If there's no cancer present, why remove a woman's ovaries during hysterectomy? Does the reduced risk of ovarian cancer outweigh the consequences of eliminating the protective hormones secreted by a healthy pair of ovaries? A team of researchers offers some thought-provoking conclusions.
The cumulative lifetime mortality rate for women from ovarian cancer after hysterectomy for benign disease is 0.47%, or fewer than one in 200. This is lower than the often-stated lifetime risk of one in 70, a number that includes women with BRCA1 or BRCA2 mutations or other high-risk germ-line mutations.
Despite these important health concerns, many women feel that they do not have enough information about long-term risks and benefits to help them make a decision regarding the prophylactic removal of ovaries when they are having a hysterectomy for benign disease.3 A recent decision analysis for women with inherited BRCA1/2 mutations and at high risk for ovarian cancer (and breast cancer) found that prophylactic oophorectomy was clearly beneficial after completion of childbearing.4 But a recommendation for women with average risk of ovarian cancer has not been established.
The ideal way to study this issue would be with a prospective, randomized trial. However, to be statistically valid and yield meaningful outcomes, such a study would require 8,000 women randomized to oophorectomy or ovarian conservation and then followed for 40 years. So it's unlikely that outcomes will ever be studied in this way.
Gender discrepancy found in ABCA4-associated retinopathy
April 18th 2024A recent meta-analysis suggests sex as a modifying factor in the development of ABCA4-associated retinopathy, revealing a higher proportion of women among individuals with a mild reduced penetrant ABCA4 variant, impacting prognosis predictions and recurrence risks.
Read More